DOMINOS PIZZA ENTERPRISES LIMITED UNSP ADR EACH REPR 0.5 ORD SHS
DMZPY
DexCom
DXCM
Hutchmed (China)
HCM
New Fortress Energy
NFE
Enerpac Tool
EPAC
US Stock MarketDetailed Quotes
ACRS Aclaris Therapeutics
- 2.330
- +0.130+5.91%
Close Feb 14 16:00 ET
- 2.320
- -0.010-0.43%
Post 20:01 ET
249.35MMarket Cap-4.48P/E (TTM)
2.350High2.170Low473.67KVolume2.180Open2.200Pre Close1.09MTurnover0.64%Turnover RatioLossP/E (Static)107.02MShares5.17052wk High1.92P/B173.09MFloat Cap0.95252wk Low--Dividend TTM74.29MShs Float33.880Historical High--Div YieldTTM8.18%Amplitude0.590Historical Low2.292Avg Price1Lot Size
Aclaris Therapeutics News
Aclaris Therapeutics | 8-K: Current report
Aclaris Therapeutics | S-3: Registration statement for specified transactions by certain issuers
Aclaris Therapeutics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Aclaris Therapeutics | 8-K: Current report
Aclaris Therapeutics | 8-K: Current report
Aclaris Therapeutics | 8-K: Current report
Aclaris Therapeutics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Aclaris Therapeutics | DEFA14A: Others
Aclaris Therapeutics | DEF 14A: Definitive information statements
Aclaris Therapeutics | 8-K: Current report
Aclaris Therapeutics | 8-K/A: Current report (Amendment)
Aclaris Therapeutics | 8-K: Current report
Aclaris Therapeutics | 8-K: Current report
Aclaris Therapeutics | 8-K: Current report
Aclaris Therapeutics | 8-K: Current report
Aclaris Therapeutics | 8-K: Current report
Aclaris Therapeutics | 8-K: Current report
Aclaris Therapeutics | 8-K: Current report
Aclaris Therapeutics | 8-K: Current report
Aclaris Therapeutics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans